Co-administration of HDAC inhibitors with perifosine (an Akt inhibitor) and rapamycin (an mTOR inhibitor) in human leukemia cells also promotes mitochondria injury and apoptosis [28, 29]. This evidence concerns the gene AKT1 and leukemia.